News

001) and an average of 31.9% of patients using it. “While we weren’t surprised that there was variation in high-flow nasal cannula usage in non-intensive care patients, we were very surprised ...
High-flow nasal cannula manufacturers are leveraging the acute shortage of ventilators during the coronavirus pandemic, with an effective low-cost treatment alternative. ROCKVILLE, MD / ACCESSWIRE ...
New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “High-Flow Nasal Cannula Market By End-User (Long-Term Care Centers, Hospitals ...
[1] A multicenter, randomized trial [2] evaluated whether high-flow nasal cannula oxygen therapy ... or infection with respiratory syncytial virus did not demonstrate a difference in the primary ...
Objective: High-flow humidified nasal cannula is often used to provide noninvasive respiratory support in children. The effect of high-flow humidified nasal cannula on effort of breathing in ...
High-flow nasal cannula (HFNC) treatment for patients with mild to moderate bronchiolitis may be associated with longer hospital stays and higher cost of care, according to a study led by Le ...
A nasal cannula is a medical device that provides supplemental oxygen therapy to people who have lower oxygen levels. There are two types of nasal cannulas: low flow and high flow. The device has ...
Treating bronchiolitis outside the ICU with weight-based high-flow nasal cannula protocols reduced ICU admissions. Use of noninvasive positive pressure ventilation also went down with these protocols.
High-flow nasal cannula (HFNC) oxygen therapy is a relatively recent innovation in adult critical care units. It delivers warm humidified oxygen at high flow rates (between 15 and 60 L/min) through a ...
Sales of global high flow nasal cannula Industry size are anticipated to increase between 2022 and 2030 at a CAGR of 11.6%. By 2030, the market for high flow nasal cannulas is expected to be valued ...
The global high flow nasal cannula market is set to experience a notable downturn over the next decade, with forecasts indicating a decline from USD 1,369.3 million in 2024 to USD 1,063.0 million by ...
More information: Jeffrey C. Winer et al, Variation and Outcomes of Hospital-Level High-Flow Nasal Cannula Usage Outside of Intensive Care, Hospital Pediatrics (2022). DOI: 10.1542/hpeds.2022-006660 ...